Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps ...

Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in ...

Medtronic (MDT) has recently initiated the ELEVATE-HFpEF study focusing on heart failure treatment, which, alongside other product developments and strategic initiatives, coincides with a positive ...

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...

Abbott Laboratories (NYSE:ABT) reported a 6.9% increase in sales for the second quarter of 2025. The earnings report, ...

MDT delivered solid fiscal Q1 2026 results, with 8.4% revenue growth and standout performance in Cardiac Ablation and Diabetes segments. Read the latest analysis on the stock here.

For the growing number of children with type 1 diabetes, the daily burden of managing their challenging chronic disease and ...

Biolinq Shine’s use of a microsensor array mitigates the need for an introducer needle for sensor placement as in traditional ...

The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...

The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, expanding at ...

The global Diabetes Care Devices Market , valued at US$30.8 billion in 2024, stood at US$34.3 billion in 2025 and is projected to advance at a resilient CAGR of 12.3% from 2025 to 2030, culminating in ...